advertisement
Clinical and Experimental Optometry 31
Showing records 1 to 25 | Display all abstracts in Clinical and Experimental Optometry117752 Glaucoma Agreement in New Zealand (GAINZ)
Green S
Clinical and Experimental Optometry 2024; 107: 204-212
118322 Which glaucoma patients benefit from 10-2 visual field testing? Proposing the functional vulnerability zone framework
Phu J
Clinical and Experimental Optometry 2024; 107: 171-183
118548 Optical coherence tomography angiography in the diagnosis of ocular disease
Kalloniatis M
Clinical and Experimental Optometry 2024; 107: 482-498
117749 Optical coherence tomography angiography in glaucoma
Hong J
Clinical and Experimental Optometry 2024; 107: 110-121
118555 Intraocular pressure fluctuations assessment in professional wind instrument players
Noya-Padin V
Clinical and Experimental Optometry 2024; 0: 1-6
117554 The effect of macular visual field test density on central structure-function concordance in glaucoma
Rafla D
Clinical and Experimental Optometry 2024; 0: 1-10
118237 Understanding and identifying visual field progression
McKendrick AM
Clinical and Experimental Optometry 2024; 107: 122-129
118272 Even-number measurement bias with Goldmann applanation tonometry in patients with glaucoma and glaucoma suspects
Shahid A
Clinical and Experimental Optometry 2024; 107: 192-195
118322 Which glaucoma patients benefit from 10-2 visual field testing? Proposing the functional vulnerability zone framework
Rafla D
Clinical and Experimental Optometry 2024; 107: 171-183
117749 Optical coherence tomography angiography in glaucoma
Tan SS
Clinical and Experimental Optometry 2024; 107: 110-121
118555 Intraocular pressure fluctuations assessment in professional wind instrument players
Pena-Verdeal H
Clinical and Experimental Optometry 2024; 0: 1-6
117554 The effect of macular visual field test density on central structure-function concordance in glaucoma
Kalloniatis M
Clinical and Experimental Optometry 2024; 0: 1-10
118548 Optical coherence tomography angiography in the diagnosis of ocular disease
Wang H
Clinical and Experimental Optometry 2024; 107: 482-498
118237 Understanding and identifying visual field progression
Turpin A
Clinical and Experimental Optometry 2024; 107: 122-129
117752 Glaucoma Agreement in New Zealand (GAINZ)
Ng RJ
Clinical and Experimental Optometry 2024; 107: 204-212
118272 Even-number measurement bias with Goldmann applanation tonometry in patients with glaucoma and glaucoma suspects
Patel K
Clinical and Experimental Optometry 2024; 107: 192-195
118548 Optical coherence tomography angiography in the diagnosis of ocular disease
Phu J
Clinical and Experimental Optometry 2024; 107: 482-498
117752 Glaucoma Agreement in New Zealand (GAINZ)
Phillips G
Clinical and Experimental Optometry 2024; 107: 204-212
118272 Even-number measurement bias with Goldmann applanation tonometry in patients with glaucoma and glaucoma suspects
Kingra RK
Clinical and Experimental Optometry 2024; 107: 192-195
118322 Which glaucoma patients benefit from 10-2 visual field testing? Proposing the functional vulnerability zone framework
Kalloniatis M
Clinical and Experimental Optometry 2024; 107: 171-183
117749 Optical coherence tomography angiography in glaucoma
Chua J
Clinical and Experimental Optometry 2024; 107: 110-121
118555 Intraocular pressure fluctuations assessment in professional wind instrument players
Nores-Palmas N
Clinical and Experimental Optometry 2024; 0: 1-6
117554 The effect of macular visual field test density on central structure-function concordance in glaucoma
Phu J
Clinical and Experimental Optometry 2024; 0: 1-10
118555 Intraocular pressure fluctuations assessment in professional wind instrument players
Giraldez MJ
Clinical and Experimental Optometry 2024; 0: 1-6
118272 Even-number measurement bias with Goldmann applanation tonometry in patients with glaucoma and glaucoma suspects
Rozwat AS
Clinical and Experimental Optometry 2024; 107: 192-195
